Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Division of Immunology and Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA.
Rheumatology (Oxford). 2023 Mar 29;62(Suppl 1):i4-i9. doi: 10.1093/rheumatology/keac610.
SLE is a global health concern that unevenly affects certain ethnic/racial groups. Individuals of Asian, Black, Hispanic and Indigenous ethnicity/race are amongst those who experience increased prevalence, incidence, morbidity and mortality. Population-based surveillance studies from many regions are few and often still in nascent stages. Many of these areas are challenged by restricted access to diagnostics and therapeutics. Without accurately capturing the worldwide burden and distribution of SLE, appropriately dedicating resources to improve global SLE outcomes may be challenging. This review discusses recent SLE epidemiological studies, highlighting the challenges and emerging opportunities in low- and middle-income countries. We suggest means of closing these gaps to better address the global health need in SLE.
SLE 是一个全球性的健康问题,在某些族裔/种族群体中分布不均。亚洲人、黑种人、西班牙裔和原住民等族裔/种族的个体,其患病率、发病率、发病率和死亡率较高。来自许多地区的基于人群的监测研究很少,而且往往仍处于起步阶段。这些地区中的许多地区都面临着诊断和治疗方法受限的挑战。如果不能准确地捕捉到 SLE 的全球负担和分布,那么为改善全球 SLE 结局而适当投入资源可能会具有挑战性。本综述讨论了最近的 SLE 流行病学研究,重点介绍了中低收入国家所面临的挑战和新出现的机遇。我们建议采取一些措施来缩小这些差距,以更好地满足 SLE 的全球健康需求。